Biomarker Discovery & Development | Whitepapers & Reports
Merck - Middle-Up Mass Analysis Protease Digested Cetuximab
28 February 2023
A complete reversed phase UHPLC-MS workflow has been developed to simplify middle-up mass analysis of an immunoglobulin G antibody.
Related Resources
Related Online Activities
Join the conversation with our upcoming Monthly Science Exchanges and Webinars:Subscribe to our newsletter
Sign up for our monthly Newsletter to keep up with all things Precision Medicine